pI: 10.1255 |
Length (AA): 300 |
MW (Da): 33743 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 4
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
40 | 97 | 3a5p (A) | 40 | 104 | 33.00 | 0 | 0.14 | 0.273732 | 1.61 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | epimastigote. | Smircich P |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_127767)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G55360 | very-long-chain enoyl-CoA reductase |
Babesia bovis | BBOV_III001830 | 3-oxo-5-alpha-steroid 4-dehydrogenase family protein |
Brugia malayi | Bm1_42555 | Synaptic glycoprotein SC2 |
Candida albicans | CaO19.10803 | potential steroid 5-alpha-reductase similar to S. pombe SPBC646.07c and to S. cerevisiae TSC13 (YDL015C) ER protein involved in |
Candida albicans | CaO19.3293 | potential steroid 5-alpha-reductase similar to S. pombe SPBC646.07c and to S. cerevisiae TSC13 (YDL015C) ER protein involved in |
Caenorhabditis elegans | CELE_C15F1.6 | Protein ART-1 |
Cryptosporidium hominis | Chro.20132 | hypothetical protein |
Cryptosporidium parvum | cgd2_1200 | steroid reductase like intregral membrane protein with 4x transmembrane domains and an ubiquitin domain at its N-terminus |
Dictyostelium discoideum | DDB_G0270270 | synaptic glycoprotein SC2-like protein |
Drosophila melanogaster | Dmel_CG10849 | CG10849 gene product from transcript CG10849-RA |
Echinococcus granulosus | EgrG_001150000 | synaptic glycoprotein sc2 |
Entamoeba histolytica | EHI_076870 | 3-oxo-5-alpha-steroid 4-dehydrogenase domain-containing protein |
Entamoeba histolytica | EHI_045030 | trans-2,3-enoyl-CoA reductase, putative |
Echinococcus multilocularis | EmuJ_001150000 | synaptic glycoprotein sc2 |
Giardia lamblia | GL50803_88581 | Synaptic glycoprotein SC2 |
Homo sapiens | ENSG00000099797 | trans-2,3-enoyl-CoA reductase |
Leishmania braziliensis | LbrM.25.2220 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Leishmania donovani | LdBPK_251850.1 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Leishmania infantum | LinJ.25.1850 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Leishmania mexicana | LmxM.25.1770 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Mus musculus | ENSMUSG00000031708 | trans-2,3-enoyl-CoA reductase |
Neospora caninum | NCLIV_014950 | trans-2,3-enoyl-CoA reductase, putative |
Oryza sativa | 4324516 | Os01g0150000 |
Plasmodium berghei | PBANKA_0912700 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Plasmodium falciparum | PF3D7_1135900 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Plasmodium knowlesi | PKNH_0934100 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Plasmodium vivax | PVX_092410 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Plasmodium yoelii | PY03009 | hypothetical protein |
Saccharomyces cerevisiae | YDL015C | trans-2-enoyl-CoA reductase (NADPH) TSC13 |
Schistosoma japonicum | Sjp_0213210 | ko:K10258 enoyl reductase, putative |
Schistosoma mansoni | Smp_081820.3 | synaptic glycoprotein sc2 related |
Schistosoma mansoni | Smp_081820.1 | synaptic glycoprotein sc2 related |
Schistosoma mansoni | Smp_081820.4 | synaptic glycoprotein sc2 related |
Schmidtea mediterranea | mk4.000087.20 | Probable very-long-chain enoyl-CoA reductase art-1 |
Trypanosoma brucei gambiense | Tbg972.3.1700 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Trypanosoma brucei | Tb927.3.1840 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Trypanosoma congolense | TcIL3000_3_970 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.437545.10 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Toxoplasma gondii | TGME49_285240 | 3-oxo-5-alpha-steroid 4-dehydrogenase |
Theileria parva | TP03_0656 | 3-oxo-5-alpha-steroid 4-dehydrogenase, putative |
Trichomonas vaginalis | TVAG_080870 | synaptic glycoprotein sc2, putative |
Trichomonas vaginalis | TVAG_231320 | synaptic glycoprotein sc2, putative |
Trichomonas vaginalis | TVAG_032770 | synaptic glycoprotein sc2, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.1840 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1840 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1840 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.3.1840 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YDL015C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0912700 | Plasmodium berghei | Essential | plasmo |
TGME49_285240 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.